Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →
logo
Get CLEATUSFree Trial

DIBUCAINE OINTMENT

Active
SPE2DP-26-T-4418Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Dibucaine Ointment USP is a topical pharmaceutical product containing 1 percent dibucaine as the active ingredient, formulated for rectal administration and external use only. It is supplied in a collapsible tube and includes a rectal applicator, with each unit of issue being a single package containing one ounce or 28 grams of ointment. The product must be stored at temperatures between 15 and 30 degrees Celsius (59 to 86 degrees Fahrenheit) and carries a non-extendable shelf life of 36 months, classified as a TYPE I (CODE Q) item. Packaging and marking must comply with the latest edition of the Medical Marking Standard No. 1 and MIL-STD-2073-1E, ensuring proper government logistics handling. The item is regulated by the FDA, and procurement requires a referral through EBS to verify compliance before award. This product is procured under solicitation SPE2DP-26-T-4418 with a required delivery within five days to Offutt AFB, zip 68113-1044, under FOB destination terms. Quantity is fixed at one package (PG) with zero variance allowed, and inspection and acceptance occur at the delivery point. The National Stock Number is 6505-00-299-9535, and the NDC code is 00536-1211-95. The supplier is The Harvard Drug Group, L.L.C., and the procurement is managed by the Department of Defense’s Medical Supply Chain Pharmacy FSA. Contract data specifies a response deadline of August 10, 2026, with technical and quality requirements governed by the DLA Master List of Technical and Quality Requirements. Covered Defense Information may apply under RD003, and removal of government identification from non-accepted supplies is required per RQ011.

General Info

Dibucaine ointment USP, 1%, rectal/external use, 28g tube, 36-month shelf life, FOB destination, NSN 6505-00-299-9535.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

2501 CAPEHART RD STE 1105, OFFUTT AFB, NE, 68113-1044, US

Set-Aside

NONE

Documents

(1)

SPE2DP-26-T-4418.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS
Contacts
Alec Deichman
contact@example.gov
+1 (555) 000-0000

Full Description

Show more
DIBUCAINE OINTMENT
DIBUCAINE OINTMENT<(>,<)> USP. CONTAINS 1 PERCENT OF DIBUCAINE OINTMENT
AS THE ACTIVE INGREDIENT. COMES SUPPLIED IN A COLLAPSIBLE TUBE AND
RECTAL APPLICATOR. RECTALLY ADMINISTERED. FOR EXTERNAL USE ONLY. UNIT OF
ISSUE IS A PACKAGE CONTAINING ONE (1) OUNCE OR 28 GRAMS. STORE AT 15-30
DEGREES CELSIUS OR 59 TO 86 DEGREES FARENHEIT.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/
THE HARVARD DRUG GROUP, L.L.C. 1LEZ0 P/N NDC00536-1211-95
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017701235 0001 PG 1.000
NSN/MATERIAL:6505002999535
DELIVERY (IN DAYS):0005
SPE2DP-26-T-4418
SECTION B
PR: 7017701235 PRLI: 0001 CONT’D
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-00-299-9535 Quantity: 1 PG Purchase Request: 7017710760QTY: 3 Delivery: 5 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
ALUMINUM HYDROXIDE GEL
Solicitation # SPE2DP-26-T-4441
ALUMINUM HYDROXIDE GEL, USP, is procured under solicitation SPE2DP-26-T-4441 with a unit of issue as one bottle (1 BT or 16 OZ), requiring compliance with DLA’s Medical Marking Standard No. 1 and labeling per MMS No. 1A dated February 4, 2013, superseding MIL-STD-129. The product must have a mandatory 24-month shelf life, with no less than 21 months remaining from the date of manufacture to the date of government delivery. Packaging must meet commercial standards, ensuring each unit is sealed and protected against damage, and shipped in exterior containers suitable for safe transport via common carrier at the lowest cost to the destination specified in the contract. All items must be marked in accordance with DLA’s Medical Marking Standard, including NSN, manufacturer and CAGE code, date of manufacture, expiration date, contract number, and lot number. The item is regulated by the FDA, requiring referral via EBS to a product specialist before award, and must be accompanied by the manufacturer’s part number NDC00536-0091-85 from Watson Pharma Inc., with CAGE code 1DWF9. Delivery is FOB destination within 20 days, with zero variance in quantity and inspection and acceptance occurring at point of delivery. Packaging must conform to MIL-STD-2073-1E, and all technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements referenced in the document.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 3 hours ago

DEADLINE

in 8 days
View Details
NAICS: 325412
New
DIBBS
HYDROGEN PEROXIDE TOPI
Solicitation # SPE2DP-26-T-4396
Hydrogen Peroxide Topical Solution, USP, is a 3% stabilized topical solution intended for external use only, with clear warnings against use in the eyes or over large body areas and a maximum usage duration of one week. Each unit is a 473-milliliter (16-fluid-ounce) bottle, requiring tight closure, storage at controlled room temperature, protection from freezing and excessive heat, and no shaking. Packaging and labeling must comply with Medical Marking Standard No. 1A dated February 4, 2013, superseding MIL-STD-129, and all units must be sealed in commercial containers suitable for transit and protected from damage. The product is regulated by the FDA and classified as a Type I (Code M) item with a non-extendable shelf life of 24 months. Suppliers must provide Safety Data Sheets (SDS) conforming to 29 C.F.R. 1910.1200 and Hazard Communication Standard (HCS) compliant labels as of June 1, 2015, and must train employees on these requirements. All packaging and shipping must meet commercial standards and ensure safe delivery at the lowest cost to the destination. The item is identified by NSN 6505-00-153-8480, with a purchase request number of 7017684184 and a quantity of 20 bottles. Delivery is FOB destination within 20 days, with zero variance allowed. Solicitation number SPE2DP-26-T-4396, posted August 2, 2026, requires response by August 10, 2026. Approved manufacturers include McKesson, Cardinal Health, and Medline Industries. The contract is administered by the Department of Defense’s Medical Supply Chain, with delivery to Pineville, LA, and point of contact Patrell Postell. All requisitions previously associated with DMLIIS Request ID 1721935 under ACC-L have been canceled without replacement, transitioning to ACCY.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 3 hours ago

DEADLINE

in 8 days
View Details
NAICS: 325412
New
DIBBS
PETROLATUM, WHITE
Solicitation # SPE2DP-26-T-4447
The contract specifies the procurement of Petrolatum, White, USP, with a unit of issue of 1 TU equaling 28 mg, and a total quantity of 1 TU required. The item has a non-extendable shelf life of 36 months and must be packaged in accordance with the Medical Marking Standard No. 1, which supersedes MIL-STD-129, and all packaging must ensure protection against damage and compliance with commercial shipping standards for safe delivery to the destination. The material is not classified as hazardous under FED-STD-313 and must be commercially packaged per ASTM D3951, though any conflicting requirements from the DLA Master List of Technical and Quality Requirements take precedence. Labeling and marking of all containers must strictly follow the latest edition of Medical Marking Standard No. 1, and packaging must be palletized per RP001, using the designated unit pack configuration and ensuring the lowest freight cost to the specified delivery point. Delivery is required within five days of award, FOB destination, with zero variance allowed in quantity, and inspection and acceptance occur upon arrival. The item is to be shipped by the fastest traceable means, excluding parcel post, to the government address in Morrisville, NC, with explicit instructions to avoid using outdated or non-compliant marking systems. The solicitation is issued under contract SPE2DP-26-T-4447, with a required delivery date of August 4, 2026, and the item is identified by NSN 6505-00-254-5527 and NDC 53329-0068-01, supplied by Medline Industries, LP.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 3 hours ago

DEADLINE

in 8 days
View Details
NAICS: 325412
New
DIBBS
ANESTHESIA SET, EPIDURA
Solicitation # SPE2DS-26-T-298A
The contract specifies the procurement of an epidural anesthesia set featuring a 20 gauge catheter and a 17 gauge Tuohy Schliff winged needle, with each package containing ten complete sets. The set comprises 29 components and must be delivered in its original packaging with a minimum shelf life of 12 months, ensuring no more than two months have elapsed between the date of manufacture and the date of delivery to the government. The item is identified by NSN 6515-01-323-6531 and is subject to stringent technical and quality requirements outlined in the DLA Master List of Technical and Quality Requirements, which governs compliance for both simplified and large acquisitions based on solicitation or award dates. Packaging must adhere to DLA standards, and non-accepted supplies must have all government identification removed prior to return. Bidders are required to clearly state the source and part number being supplied. The solicitation, issued under SPE2DS-26-T-298A, has a response deadline of August 10, 2026, with a required delivery within 20 days of award, and is managed by the Department of Defense’s Medical Supply Chain through the point of contact James Burke.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

about 3 hours ago

DEADLINE

in 8 days
View Details
NAICS: 325412
New
DIBBS
OMEPRAZOLE EXTENDED-RE
Solicitation # SPE2DP-26-T-4402
Omeprazole extended-release capsules, 20 mg in 30-count units, are procured under solicitation SPE2DP-26-T-4402 for government use with a total requirement of 23,000 units across multiple contract line items. Each unit must be packaged in sealed containers that protect against damage and shipped in commercial exterior containers to ensure safe, low-cost delivery to designated government destinations. The product must be stored at controlled room temperature between 20 and 25 degrees Celsius and carries a non-extendable shelf life of 18 months. All packaging and labeling must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and conform to DLA packaging requirements including palletization and hazardous material handling per Fed-Std-313 and ASTM D3951 where applicable. The item is regulated by the FDA and requires supplier verification through EBS referral. Shipments must be sent by traceable means only, excluding parcel post, and deliveries are required FOB destination within five days of ship date. The original required delivery date for all orders is no later than August 4, 2026, with one contract line due by July 30, 2026. The contract includes multiple delivery addresses across Fort Lewis, Washington, and Watervliet Arsenal, New York, with strict adherence to unit of issue and quantity per unit pack specifications. The sole source manufacturers listed include Astra Pharmaceutical Products Inc, Sandoz Inc, Amerisource Health Services LLC, and Golden State Medical Supply Inc, with NDC numbers specified for each.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 3 hours ago

DEADLINE

in 8 days
View Details
NAICS: 325412
New
DIBBS
PERMETHRIN CREAM RINSE
Solicitation # SPE2DP-26-T-4404
Permethrin Cream Rinse is a 1% w/v topical pharmaceutical product packaged in a 2 fluid ounce plastic squeeze bottle, each unit including a comb for application. The product has a 24-month shelf life, with a mandatory minimum of 21 months remaining at the time of receipt by the first government activity. It is regulated by the FDA and subject to strict medical acquisition standards, including commercial packaging requirements that ensure the unit is sealed and protected from damage, and shipments are placed in suitable exterior containers for safe transport at the lowest carrier rate. All items must be marked in compliance with Medical Marking Standard No. 1, replacing all references to MIL-STD-129. The product is hazardous and requires compliance with Federal Standard No. 313-E, mandating submission of current Safety Data Sheets (SDS) formatted per 29 C.F.R. 1910.1200 and appropriate Hazard Communication Standard labels prior to award. Each shipment must include a physical copy of the SDS, and suppliers must submit these documents to DLA.MSDS@DLA.MIL with a completed cover sheet. Packaging must meet 49 CFR and ICAO regulations for hazardous materials. Technical and quality requirements are governed by the DLA Master List, and the procurement is subject to Hazard Communication Standard updates. The NSN is 6505-01-256-4972, and the solicitation requires delivery of five units within five days of award, with the contract issued under SPE2DP-26-T-4404 by the Department of Defense, Medical Supply Chain Pharm FSA.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 3 hours ago

DEADLINE

in 8 days
View Details
NAICS: 325412
New
DIBBS
ALBUTEROL SULFATE INHA
Solicitation # SPE2DP-26-T-4437
Albuterol Sulfate Inhalation Aerosol with HFA is a prescription-only medication for oral inhalation, with each actuation delivering 108 micrograms of albuterol sulfate equivalent to 90 micrograms of albuterol base, supplied in an 8.5-gram canister containing 200 metered doses. The product must be stored at room temperature between 59°F and 77°F, protected from extreme heat or cold, and must not be punctured, exposed to flames, or stored near heat sources, as temperatures above 120°F may cause the canister to burst. It is subject to a non-extendable 24-month shelf life and must be labeled with the National Stock Number, manufacturer name, date of manufacture, expiration date, contract number, and lot number. All packaging and marking must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and must be shipped in sealed commercial unit containers and approved shipping containers suitable for safe transport at the lowest rate to the delivery point specified. The product is regulated by the FDA and requires submission of Safety Data Sheets and Hazard Communication Standard-compliant labels as mandated by OSHA’s Globally Harmonized System, with supplier training on these requirements. Delivery is FOB destination within five days, with zero tolerance for quantity variance, and inspection and acceptance occur at the delivery point. The contract is issued under solicitation SPE2DP-26-T-4437 for a quantity of 12 units, with the National Stock Number 6505015436562, and references applicable DLA technical and quality requirements contained in the DLA Master List.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 3 hours ago

DEADLINE

in 8 days
View Details
NAICS: 325412
New
DIBBS
CHLORINE TEST REAGE
Solicitation # SPE2DS-26-T-295L
The contract specifies the procurement of chlorine test reagent in powder pillow form, with each package containing 100 individual 10 mL samples, packaged as one unit of issue labeled PG. The product is designated by NSN 6550-01-460-7597 and is subject to strict technical and quality standards referenced in the DLA Master List of Technical and Quality Requirements, with compliance controlled by the revision in effect at the solicitation or award date. The item is classified as a TYPE I (CODE S) medical supply with a non-extendable shelf life of 60 months, and no more than eight months may have elapsed between the date of manufacture and delivery to the government. Packaging must meet commercial standards as outlined in Medical Marking Standard No. 1, which supersedes MIL-STD-129, and all labels must clearly display the date of manufacture, expiration or retest date, and the contract or lot number in accordance with MMS1C. The item must be securely packaged in sealed unit containers and shipped in commercial exterior containers suitable for safe transport via common carriers at the lowest possible rate to the designated delivery point. The procurement is issued under solicitation SPE2DS-26-T-295L, with a response deadline of August 10, 2026, and a delivery requirement within 20 days after award. The contracting activity is under the Department of Defense’s Medical Supply Chain, and all packaging, marking, and documentation must fully comply with the applicable DLA requirements for defense medical acquisitions.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

about 3 hours ago

DEADLINE

in 8 days
View Details
NAICS: 325412
New
DIBBS
ZINC OXIDE OINTMENT
Solicitation # SPE2DP-26-T-4398
Zinc Oxide Ointment USP, 20% strength in 1-ounce collapsible tubes, is procured under contract SPE2DP-26-T-4398 with a total order of 100 tubes across nine line items, each designated by a unique CLIN and purchase request number. The product is classified as a topical skin protectant and must be stored at controlled room temperature not exceeding 30°C (86°F). Each tube contains 28.35 grams and is packaged as a single unit of issue (TU), with strict adherence to packaging standards including MIL-STD-129 and the Medical Marking Standard No. 1, which supersedes all other marking requirements. All packaging must comply with DLA’s Master List of Technical and Quality Requirements, with ASTM D3951 applying only if the material is non-hazardous per FED-STD-313; hazardous material must meet IP025 requirements. The item is regulated by the FDA, and bidders must be verified through an EBS referral. Shelf life is fixed at 36 months with no extension permitted, and the product must be marked with its NDC number (67777-0223-11) and manufacturer details (Dynarex Corp, P/N 1190). Delivery is FOB destination with zero variance allowance, inspection and acceptance occurring at the point of delivery. Shipments must use traceable freight methods only and avoid parcel post. Packaging must ensure protection from damage and conform to commercial standards, with palletization following RP001 guidelines. Eight delivery locations span military installations across North Carolina, Virginia, Louisiana, Massachusetts, and other states, with specified delivery dates ranging from July 15, 2026, to August 4, 2026. Unit price is fixed at $3.00 per tube across all line items, with total contract value reflecting aggregated quantities.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 3 hours ago

DEADLINE

in 8 days
View Details
NAICS: 325412
New
DIBBS
MICONAZOLE NITRATE
Solicitation # SPE2DP-26-T-4428
Miconazole Nitrate Cream, USP 2% in a 1 oz tube is procured under solicitation SPE2DP-26-T-4428 with a unit of issue as a tube and a required shelf life of 36 months, of which no less than 31 months must remain from the date of manufacture to the date of delivery to the Government. The product must be manufactured by Taro Pharmaceuticals U.S.A., Inc. with NDC 51672-2001-02 and complies with all applicable FDA regulations. Packaging must adhere strictly to Commercial Packaging standards as specified in the DLA Master List of Technical and Quality Requirements, with each unit sealed in a protective container and shipped in commercial exterior containers suitable for safe transit at the lowest carrier rate. Marking must follow Medical Marking Standard No. 1A dated February 4, 2013, superseding MIL-STD-129, and all external labeling must conform to this standard. The item must be stored at controlled room temperature between 59°F and 86°F (15°C–30°C). Delivery is due within 20 days FOB destination, with no tolerance for quantity variance, and inspection and acceptance occur at the delivery point. The procurement is governed by DLA packaging and quality requirements, and all documentation, including packaging and labeling, must align with DLA’s Medical Marking Standard No. 1. The NSN is 6505010043508, and the purchase request number is 7017693914.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 3 hours ago

DEADLINE

in 8 days
View Details
NAICS: 325412
New
DIBBS
SODIUM CHLORIDE INJECT
Solicitation # SPE2DP-26-T-4440
Sodium Chloride 0.9% Injection, USP, in 250 mL units, is procured under contract SPE2DP-26-T-4440 with a requirement for 4 packaging groups, each containing 24 bags, totaling 96 bags. The product must comply with all technical and quality specifications outlined in the DLA Master List of Technical and Quality Requirements, including packaging and marking standards per Medical Marking Standard No. 1, which supersedes MIL-STD-129. Each unit must be sealed in commercial-grade containers that protect against damage and breakage, and shipped in exterior containers suitable for safe delivery via common carrier at the lowest cost to the designated destination. The product is regulated by the FDA and must be marked with the NDC00264-7800-20 identifier or equivalent approved part numbers from approved manufacturers including B. Braun Medical Inc., Trillamed LLC, and Cardinal Health. The item has a non-extendable shelf life of 24 months and must be stored at room temperature (25°C), with limited tolerance for brief exposure up to 40°C; it must be protected from freezing and excessive heat. Delivery is required within five days FOB destination with zero variance tolerated, and inspection and acceptance occur upon delivery. All packaging and labeling must conform to MIL-STD-2073-1E, and the NSN is 6505-01-331-8945. The contracting official must submit a referral in EBS to confirm bidder and manufacturer details prior to award.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 3 hours ago

DEADLINE

in 8 days
View Details
NAICS: 325412
New
DIBBS
NORETHINDRONE AND E
Solicitation # SPE2DP-26-T-4414
The contract specifies the procurement of Norethindrone and Ethinyl Estradiol Tablets USP, a hormonal contraceptive regulated by the FDA, in a standardized 28-tablet cycle format with three distinct active ingredient strengths: 7 tablets of 0.5 mg Norethindrone and 35 mcg Ethinyl Estradiol, 7 tablets of 0.75 mg and 35 mcg, and 7 tablets of 1 mg and 25 mcg, followed by 7 inert tablets per cycle. Each package unit consists of six 28-tablet cycles, totaling 168 tablets per package, with a required shelf life of 36 months from manufacture, ensuring no less than 31 months remain until delivery to the government. Packaging must comply strictly with Medical Marking Standard No. 1, superseding MIL-STD-129, and must be enclosed in sealed unit containers protected from damage, packed in commercial shipping containers suitable for safe transport at the lowest cost to the delivery point. The product is to be manufactured by TEVA PHARMACEUTICALS USA, INC., identified by NDC 00555-9012-58, and stored at 25°C (77°F) with allowable excursions between 15°C and 30°C. Delivery is required FOB destination within 20 days, with no tolerance for quantity variance. The contract, issued under solicitation SPE2DP-26-T-4414, references DLA’s Master List of Technical and Quality Requirements and mandates adherence to all applicable DLA packaging, marking, and logistics standards including MIL-STD-2073-1E for preparation. The contracting officer must confirm bidder and manufacturer details via EBS referral prior to award.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 3 hours ago

DEADLINE

in 8 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 424210
New
DIBBS
SODIUM CHLORIDE INJECT
Solicitation # SPE2DP-26-T-4397
Sodium Chloride Injection USP 0.9% in 1000ml plastic bags, latex free, is being procured under solicitation SPE2DP-26-T-4397 with a unit of issue defined as one package of twelve units. The product must comply with strict technical and quality requirements as defined in the DLA Master List of Technical and Quality Requirements and must adhere to Medical Marking Standard No. 1, superseding all references to MIL-STD-129. Packaging must be commercial-grade, sealed, and designed to protect against damage and breakage, with exterior shipping containers ensuring safe and cost-effective delivery to the destination point. The item is regulated by the FDA and has a non-extendable shelf life of 30 months, with storage required at controlled room temperature between 20°C and 25°C, protection from excessive heat and freezing, and segregation from incompatible materials. The sole approved manufacturer is B. Braun Medical Inc with part number NDC00264-5802-00, though other vendors may submit bids under their respective part numbers. The contract specifies a firm quantity of twelve units per package, with zero variance permitted, and requires delivery within five days FOB destination to Carville, LA 70721. Inspection and acceptance occur at the delivery point. All markings, documentation, and compliance must align with current DLA standards, and buyers must refer specific bidder and manufacturer details to the DLA product specialist via EBS for confirmation prior to award.
Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

about 3 hours ago

DEADLINE

in 8 days
View Details
NAICS: 325411
New
DIBBS
PSYLLIUM HYDROPHILIC M
Solicitation # SPE2DP-26-T-4405
The contract is for the procurement of Psyllium Hydrophilic Mucilloid in 12-gram packets, each containing 25 mg of potassium and 5 mg of sodium, packaged in units of 30 packets per case. This product is regulated by the FDA and must be supplied with its manufacturer’s part number NDC37000-0740-87, sourced from Procter & Gamble Distributing LLC. The item has a non-extendable shelf life of 24 months and must comply with DLA’s technical and quality requirements as defined in the DLA Master List, with packaging and marking strictly governed by Medical Marking Standard No. 1, which supersedes all references to MIL-STD-129. Packaging must meet MIL-STD-2073-1E and DLA-specific packaging requirements, ensuring secure, commercial-grade containment capable of protecting contents during transit. Delivery is FOB destination with no tolerance for quantity variance, and items must be shipped within five days of contract award using the fastest traceable means—parcel post is prohibited. The delivery address is a Navy vessel in FPO AP 96675, with specific shipping and marking instructions governed by DLA’s logistics protocols. The NSN is 6505-01-719-3181, and the contract number is SPE2DP-26-T-4405, with an original required delivery date of August 4, 2026. All bids must include the supplier and manufacturer details for FDA referral through EBS prior to award.
Medicinal and Botanical Manufacturing

POSTED

about 3 hours ago

DEADLINE

in 8 days
View Details
NAICS: 456199
New
DIBBS
LUBRICANT, SURGICAL
Solicitation # SPE2DP-26-T-4417
The contract is for surgical lubricant, a sterile, latex-free, water-soluble jelly containing parabens, with each foil packet containing 2.7 grams and packaged in boxes of 144 packets as the unit of issue. The product must comply with strict technical and quality requirements outlined in the DLA Master List, and all packaging and marking must adhere to the Medical Marking Standard No. 1, which supersedes MIL-STD-129. The item has a non-extendable shelf life of 36 months and must be stored at 20°C to 25°C (68°F to 77°F). It is regulated by the FDA and classified as a TYPE I (CODE Q) item with specific shelf-life controls. The supplier, MEDLINE INDUSTRIES, LP, must provide the item under part number MDS032273H, and the NSN is 6505-01-626-5774. The contract requires delivery of one box within 20 days to a designated military destination, with FOB destination terms and zero variance permitted on quantity. All packaging must be commercial-grade, sealed, and designed for safe transit with minimal cost to ensure unharmed delivery. The item must be marked according to MMS No. 1, and transportation details are governed by DLAD procedural notes. The contract is issued under solicitation SPE2DP-26-T-4417 with a required delivery date of August 4, 2026, and the point of contact is Nicholas Quigley of the Department of Defense’s Medical Supply Chain.
All Other Health and Personal Care Retailers

POSTED

about 3 hours ago

DEADLINE

in 8 days
View Details
NAICS: 423450
New
DIBBS
OMEPRAZOLE EXTENDED-RE
Solicitation # SPE2DP-26-T-4416
The contract specifies the procurement of 20 mg extended-release omeprazole capsules in 90-count bottles, identified by NSN 6505016247068 and manufacturer part number NDC00781-2868-92 from Sandoz Inc. Each unit must be packaged in commercial-grade sealed containers that protect against damage, with outer shipping containers ensuring safe, low-cost delivery to listed government destinations under FOB destination terms. A minimum of 21 months of shelf life must remain at delivery, with a total shelf life of 24 months that is non-extendable. All packaging, labeling, and marking must comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and palletization must adhere to DLA Packaging Requirements for Procurement. The product is regulated by the FDA and requires pre-award referral for confirmation. Shipments must use traceable transportation methods and explicitly prohibit parcel post. Deliveries are scheduled across multiple CLINs totaling 57 units, with a mandatory delivery window of five days and no variance allowed in quantity. All items must be labeled and stored at controlled room temperature, with packaging materials and methods governed by DLA’s Master List of Technical and Quality Requirements, which take precedence over ASTM D3951. Shipping addresses include military facilities at Fort Bragg, North Carolina, and APO AP, with required point-of-contact and program tracking information provided for government use.
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

about 3 hours ago

DEADLINE

in 8 days
View Details
NAICS: 325411
New
DIBBS
SUMATRIPTAN SUCCINATE
Solicitation # SPE2DP-26-T-4415
Sumatriptan Succinate Tablets, 100 mg, are supplied in a bottle of nine tablets and are indicated for the acute treatment of migraine with or without aura in adults. The product must be stored at controlled room temperature between 20 to 25°C (68 to 77°F) and protected from light, in compliance with USP standards. The item is regulated by the FDA and subject to strict shelf-life requirements: it has a non-extendable shelf life of 24 months as a Type I CODE M item, and must be marked according to the latest edition of Medical Marking Standard No. 1 and MIL-STD-129 for packaging and labeling. Packaging and palletization must adhere to DLA’s Packaging Requirements for Procurement and MIL-STD-2073-1E, with no tolerance for quantity variance. The contract specifies delivery FOB destination within 20 days, with inspection and acceptance occurring at the destination. The supplier is identified as MYLAN PHARMACEUTICALS INC with NDC 00378-5632-59, and the item is procured under NSN 6505-01-727-8704. Delivery is to a U.S. military address in APO AE 09094-3219, with freight originating from Ramstein, Germany. The solicitation number is SPE2DP-26-T-4415, with a required delivery date of August 4, 2026, and bid responses due by August 10, 2026. Technical and quality requirements are governed by the DLA Master List, and the contracting official must submit a referral through EBS for FDA product validation prior to award.
Medicinal and Botanical Manufacturing

POSTED

about 3 hours ago

DEADLINE

in 8 days
View Details
NAICS: 423450
New
DIBBS
SODIUM CHLORIDE INJ
Solicitation # SPE2DP-26-T-4446
Sodium Chloride Injection in 10 mL disposable syringes, preservative-free and latex-free, is being procured under contract SPE2DP-26-T-4446 with a total quantity of 2 packing groups, each containing 30 syringes for a total of 60 units. The product is regulated by the FDA and must comply with all applicable DLA Master List of Technical and Quality Requirements, including medical packaging and marking standards as defined in Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercial grade, sealed to prevent damage or breakage, and placed in exterior shipping containers suitable for safe transport at the lowest carrier rate to the designated delivery point. The item has a non-extendable shelf life of 24 months and must be labeled accordingly. Delivery is FOB destination within 20 days of award, with no tolerance for quantity variance. Freight must be shipped by traceable means, excluding parcel post, to the specified delivery location at Watervliet Arsenal, New York. The supplier, AmerisourceBergen Drug Corp with part number 106346, must adhere to all applicable hazardous material guidelines under Fed-Std-313 and ASTM D3951 where relevant, though DLA requirements override any conflicting standards. All packaging, labeling, and palletization must conform to RP001 and the latest DLA packaging directives.
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

about 3 hours ago

DEADLINE

in 8 days
View Details